SEARCH

Current Edition

Aduhelm

HHS watchdog to review FDA accelerated approval process after Aduhelm controversy

The U.S. health department’s inspector general will review how the Food and Drug Administration grants accelerated approvals of new drugs, announcing a broad investigation Wednesday …

Continue Reading →